Accredo Specialty Pharmacy Releases Mobile App for Hepatitis C Patients - FOX 42: Omaha News, Sports and Weather; kptm.com |

Accredo Specialty Pharmacy Releases Mobile App for Hepatitis C Patients

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Accredo Specialty Pharmacy

ST. LOUIS, June 24, 2014 /PRNewswire/ -- Accredo Specialty Pharmacy has recently launched Accredo Plus C, a new iOS app that empowers hepatitis C patients to take control, better manage their treatment and increase adherence.

(Logo - http://photos.prnewswire.com/prnh/20140623/120692)

Accredo Plus C is a free iPhone app available to all hepatitis C patients, regardless of pharmacy or insurance provider. The app was created by pharmacists and nurses that specialize in counseling hepatitis C patients. It leverages their disease-specific expertise to help patients derive the most out of their therapy by increasing adherence.

The app includes unique features designed specifically for hepatitis C patients and includes all hep C medications currently on the market.

Accredo Plus C offers:

  • Customized treatment schedules
  • Flexible medication reminders
  • Adherence reports
  • Treatment tracking
  • Viral load graphs
  • Options to email healthcare providers
  • Educational videos and resources

Download Accredo Plus C today from the App Store or visit http://www.AccredoPlusC.com to view screenshots and learn more about the app.

Understanding Hep C Treatment
The goal of hep C treatment is to achieve a Sustained Virologic Response – meaning absence of the virus for six months or longer following therapy completion. Patients who fail to take their full regimen of medications exactly as their physician prescribes are at risk of therapy failure and long-term consequences including liver cancer and cirrhosis. Additionally, undergoing only a partial regimen may make future therapies less effective.

Contact: Riddhi Trivedi, 314-684-6665, RTrivedi-St.Clair@express-scripts.com

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow

General Information:
contact42@kptm.com
402-558-4200

News:
news42@kptm.com
Phone: 402-554-4282
Fax: 402-554-4279

Can't find something?
Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and KPTM. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.